Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Primary graft dysfunction (PGD) is a devastating form of acute lung injury that afflicts about 10-25 per cent of patients in the first hours to days after lung transplantation. It is the leading cause of death after transplant.
Although donor lungs are tested and examined before transplant, some signs of injury may not be able to be detected by standard tests.
University of Toronto and Toronto General Research Institute researchers have developed a microelectronic chip sensor which identifies, in minutes, whether a donor lung is at risk for PGD.
Researchers Drs. Shaf Keshavjee and Shana Kelley expect that this technology will be able to alert surgeons to damaged lungs which are not suitable for transplant, and may also reduce the numbers of lungs which are discarded but may have a good molecular profile.
"Currently, only about 15 per cent of all donated lungs are transplanted, leading to a shortage of lungs," says Dr. Keshavjee, Director of the Toronto Lung Transplant Program and UHN Surgeon-in-Chief.
Read the full story